A 44-year-old man has been admitted to a hospital in Victoria with blood clots, several days after receiving the AstraZeneca vaccine, the ABC understands.

The man was vaccinated on or around March 22 and was recently admitted to Box Hill Hospital in Melbourne with serious thrombosis and a low platelet count.

It is not clear whether the man’s clots are related to the vaccine dose he received. About 30,000 Australians develop thrombosis every year.

Australia’s medical regulator, the Therapeutic Goods Administration, updated its guidance on the AstraZeneca jab last month, saying there had been no proven link between the vaccine and the development of blood clots.

The majority of Australians will receive the AstraZeneca vaccine, rather than the Pzifer BioNTech jab, as it is being locally produced in Melbourne.

LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic.

Millions of people in the UK and Europe have received the AstraZeneca vaccine.

Germany this week suspended use of the AstraZeneca vaccine for most residents under the age of 60, while Canada suspended its use in people under the age of 55.

It followed new data from the European Medicines Agency (EMA) which suggested the risk of blood clots following the vaccine is potentially as high as one in 100,000.

Most of the documented cases were people under the age of 55.

However, the TGA and the EMA continue to back the rollout of the AstraZeneca vaccine.

The EMA has said that the vaccine is not associated with an increase in blood clot risks, and its benefits outweigh any risk of side effects.

The World Health Organization has declared the vaccine safe.

An advisory note from the Australian Technical Advisory Group on Immunisation (ATAGI) on March 25 emphasised “that the benefits of the COVID-19 vaccine far outweigh this potential risk”.

Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.

How will the coronavirus vaccines work?

Federal Health Department information sheets tell recipients of the AstraZeneca vaccine that less common side effects, such as dizziness and stomach pain, are usually mild and subside in one or two days.

As with other vaccines, such as the flu jab, common side effects include pain and tenderness in the injection area, fatigue, headaches and fever.

Findings recently published in The Lancet found the AstraZeneca vaccine had an 81 per cent efficacy rate when its second dose was given three months after the first.

The exterior sign of the Box Hill Hospital, underneath which a bush of white flowers blooms next to a concrete staircase.
The man has been admitted to Box Hill Hospital in Melbourne’s east.(

ABC News: Patrick Rocca


More than 541,700 people had been vaccinated across Australia by March 28, federal data shows.

More than 115,000 doses had been administered in Victoria by Friday morning, with the majority of those being the AstraZeneca shot.

The Australian Health Protection Principal Committee (AHPPC) is meeting today, and Chief Medical Officer Paul Kelly is expected to address the media at 4:00pm.


Source link